View Older Stories View More Recent Stories
-
Intuit (INTU) PT Lowered to $430 at Mizuho
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $30 at Mizuho
-
BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
-
Femasys Inc. (FEMY) Misses Q2 EPS by 20c
-
Mizuho Reiterates Outperform Rating on Datadog (DDOG)
-
Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
-
Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
-
Traws Pharma (TRAW) Tops Q2 EPS by 27c
-
Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
-
Needham Starts Pulse Biosciences (PLSE) at Buy
-
Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
-
BTIG Downgrades Workday (WDAY) to Neutral
-
Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
-
Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
-
Trane Technologies and Eaton launch joint AI data center design
-
Vision Marine receives U.S. patent for electric vessel powertrain authentication
-
FTAI Aviation closes $2B warehouse facility for second capital vehicle
-
Red Cat's Blue Ops and Havoc partner on autonomous maritime systems
-
Babcock & Wilcox redeems $61.4M in senior notes due 2026
-
Accendra Health scraps equity program, expects CEO successor by mid-2026
-
Wells Fargo sees dollar store earnings ahead with varied outlooks
-
Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
-
Herc Holding (HRI) PT Raised to $218 at Wells Fargo
-
Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
-
Abbvie (ABBV) PT Raised to $300 at Wells Fargo
-
Wells Fargo Upgrades Okta, Inc (OKTA) to Overweight
-
CrowdStrike (CRWD) PT Raised to $230 at Wells Fargo
-
Palo Alto Networks (PANW) PT Raised to $475 at Wells Fargo
-
Paramount Global (PARA) Tops Q2 EPS by 480c
-
Apple to change ad tracking rules after German probe
-
Trump: Iran cannot have, in any way, shape, or form, a nuclear weapon
-
Morgan Stanley sees AI financing as defining summer 2026
-
BTIG Starts ADT (ADT) at Neutral
-
Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
-
Rapport Therapeutics (RAPP) PT Raised to $75 at Raymond James
-
Praxis Precision Medicines Inc. (PRAX) PT Raised to $945 at Raymond James
-
Reddit (RDDT) PT Raised to $205 at Raymond James
-
Tenon Medical (TNON) files $100M mixed shelf
-
Greenlane Holdings Inc. (GNLN) reported Q2 result
-
Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
-
LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
-
Clear Street Downgrades Kinetik Holdings, Inc. (KNTK) to Hold Citing Valuation
-
Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c
-
Paramount Global (PARA) Tops Q2 EPS by 175c
-
Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
-
Bang Mai Fang files for 5M share IPO at $5-$6/sh
-
OmniAb raises 2026 cash guidance on licensing activity
-
BeyondSpring Inc. (BYSI) Reports Q2 Loss of $0.02
-
Alopexx (ALPX) files for 3M share IPO at $10-$12/sh
-
ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy

